Oleksandr Shapoval

11PUBLICATIONS
29CO-AUTHORS
NanophotonicsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsNanomaterialsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 22, 2026
Upconverting Nanoparticles for Bimodal Luminescence and Magnetic Resonance Imaging of Langerhans Islets.

|Dec 19, 2025
Bisphosphonate-Modified Polymer-Coated NaYF4:Yb,Er,Pr Upconverting Nanoparticles for Cell Imaging: Synthesis, Physicochemical Characterization and Biosafety.

Taras Vasylyshyn, Vitalii Patsula, Oleksandr Shapoval

|Nov 26, 2025
Theranostic Verteporfin-Conjugated Upconversion Nanoparticles for Cancer Treatment.

Oleksandr Shapoval, Vitalii Patsula, David Větvička

|Jul 16, 2025
Liraglutide-Conjugated Poly(methyl vinyl ether-alt-maleic acid)-Coated Core-Shell Upconversion Nanoparticles for Theranostics of Diabetes.

Oleksandr Shapoval, Hana Engstová, Miroslav Šlouf

|Feb 05, 2025
Surface-engineered core-shell upconversion nanoparticles for effective hypericin delivery and multimodal imaging.

Taras Vasylyshyn, Veronika Huntošová, Vitalii Patsula

|Nov 21, 2024
Intraperitoneal versus intravenous administration of Flamma®-conjugated PEG-alendronate-coated upconversion nanoparticles in a mouse pancreatic cancer model.

Taras Vasylyshyn, Vitalii Patsula, David Větvička

Pageof 2

Frequent Collaborators

9 joint publications

Daniel Horák

4 joint publications

Miroslav Šlouf

4 joint publications

Vít Herynek

3 joint publications

Petr Matouš